April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ...

By Siddhi Mahatole April 20 (Reuters) - U.S. drugmaker Eli Lilly will buy privately held biotech firm Kelonia Therapeutics ...

A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, ...

Eli Lilly is in advanced talks to acquire biotech firm Kelonia ‌Therapeutics for more than $2 billion, the Wall ‌Street ...

Why Wall Street loves Lilly. So what does this Wall Street analyst like about Lilly? Yesterday, Eli Lilly announced it will ...

April 16 () - Eli Lilly said on Thursday its newly approved obesity ‌pill helped reduce the risk ‌of major cardiovascular ...

Eli Lilly's newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an ...

The FDA also asked Lilly to conduct a milk-only lactation study in women who have received a dose to assess concentrations of ...

Early prescription volume signals uptake for an oral anti-obesity entrant, but competitive positioning versus oral ...

April 20 (Reuters) - U.S. drugmaker Eli Lilly has agreed to buy privately held biotech firm Kelonia Therapeutics for up to $7 ...

By Mariam Sunny April 22 (Reuters) - A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to dent near-term demand for weight ...

Amazon will offer delivery of Eli Lilly's new weight-loss pill Foundayo and stock it at kiosks at some of the company's ...